Wan-Guang Zhang
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection (NCT07077798) | Wan-Guang Zhang | 2025-08-01 |
| QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma (NCT06822985) | Wan-Guang Zhang | 2025-02-01 |
| A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC (NCT05839197) | Wan-Guang Zhang | 2023-05-05 |
| Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC (NCT05533892) | Wan-Guang Zhang | 2022-09-01 |
Track Wan-Guang Zhang automatically
Every clearance here is in the API, with alerts when new ones post.